These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35581502)

  • 1. To give or not to give? A critical appraisal of a clinical trial on radioiodine treatment.
    Tuncel M; Vrachimis A; Campenni A; de Keizer B; Verburg FA; Kreissl MC; Ovcaricek PP; Geliashvili T; Giovanella L
    Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3316-3319. PubMed ID: 35581502
    [No Abstract]   [Full Text] [Related]  

  • 2. Approach to the patient with advanced differentiated thyroid cancer.
    Schlumberger M; Sherman SI
    Eur J Endocrinol; 2012 Jan; 166(1):5-11. PubMed ID: 21890651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioiodine treatment in pediatric Graves' disease and thyroid carcinoma.
    Yuan L; Yang J
    J Pediatr Endocrinol Metab; 2011; 24(11-12):877-83. PubMed ID: 22308835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
    Jarzab B; Handkiewicz-Junak D; Wloch J
    Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presentation and practical management to optimize radioiodine treatment of well differentiated thyroid cancer: ablation of thyroid remnants with radioiodine.
    Janisch A; Altenbrunn HJ; Markwardt J
    Radiobiol Radiother (Berl); 1987; 28(5):707-10. PubMed ID: 3441634
    [No Abstract]   [Full Text] [Related]  

  • 6. Depletion regimens for radioiodine therapy of thyroid carcinoma.
    Jackson G
    J Nucl Med; 1985 Aug; 26(8):962. PubMed ID: 4032040
    [No Abstract]   [Full Text] [Related]  

  • 7. Theranostic role of radiolabelled RGD peptide in the treatment of radioiodine-resistant thyroid cancer: A novel agent.
    Vatsa R; Sood A
    Indian J Med Res; 2020 Nov; 152(Suppl 1):S258-S259. PubMed ID: 35345242
    [No Abstract]   [Full Text] [Related]  

  • 8. Thyroid suppression and radioiodine treatment for differentiated thyroid cancer.
    Rösler H
    Arch Otolaryngol Head Neck Surg; 1987 Jul; 113(7):778-9. PubMed ID: 3580165
    [No Abstract]   [Full Text] [Related]  

  • 9. New approaches in the management of radioiodine-refractory thyroid cancer: the molecular targeted therapy era.
    Capdevila J; Argiles G; Rodriguez-Frexinos V; Nuñez I; Tabernero J
    Discov Med; 2010 Feb; 9(45):153-62. PubMed ID: 20193642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Guidelines for radioiodine therapy (RIT) in differentiated thyroid cancer].
    Dietlein M; Dressler J; Farahati J; Leisner B; Moser E; Reiners C; Schicha H; Schober O
    Nuklearmedizin; 1999; 38(6A):221-2. PubMed ID: 10510812
    [No Abstract]   [Full Text] [Related]  

  • 11. Preparation for radioiodine therapy: how to increase therapeutic efficacy and accelerate unbound radioiodine excretion.
    Matović M
    Vojnosanit Pregl; 2013 May; 70(5):504-10. PubMed ID: 23789291
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of radioiodine in the treatment of local thyroid cancer.
    Tubiana M
    Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):263-5. PubMed ID: 8823286
    [No Abstract]   [Full Text] [Related]  

  • 13. Radioiodine treatment of well-differentiated thyroid cancer.
    Wartofsky L; Van Nostrand D
    Endocrine; 2012 Dec; 42(3):506-13. PubMed ID: 22733393
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lithium as an adjuvant in the radioiodine therapy of thyroid cancer].
    Schraube P; Kimmig B; zum Winkel K
    Nuklearmedizin; 1984 Jun; 23(3):151-4. PubMed ID: 6435095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.
    Luster M; Lippi F; Jarzab B; Perros P; Lassmann M; Reiners C; Pacini F
    Endocr Relat Cancer; 2005 Mar; 12(1):49-64. PubMed ID: 15788638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioiodine ablation and therapy in differentiated thyroid cancer under stimulation with recombinant human thyroid-stimulating hormone.
    Berg G; Lindstedt G; Suurküla M; Jansson S
    J Endocrinol Invest; 2002 Jan; 25(1):44-52. PubMed ID: 11883865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid gland: thyroid surgery and radioiodine ablation-the surgeon's role.
    Luster M; Musholt TJ
    Nat Rev Endocrinol; 2013 Mar; 9(3):140-1. PubMed ID: 23183674
    [No Abstract]   [Full Text] [Related]  

  • 18. Radioiodine-refractory thyroid cancer: a complex challenge.
    Vitale G; Pellegrino G; Desiderio E; Barrea L
    Minerva Med; 2021 Dec; 112(6):686-688. PubMed ID: 34672171
    [No Abstract]   [Full Text] [Related]  

  • 19. Initial radioiodine administration: when to use it and how to select the dose.
    Esposito G
    Endocrinol Metab Clin North Am; 2014 Jun; 43(2):385-400. PubMed ID: 24891168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioiodine therapy a successful tool in treating thyroid cancer. Foreword.
    Bombardieri E; Pacini F
    Q J Nucl Med Mol Imaging; 2009 Oct; 53(5):439. PubMed ID: 20205316
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.